ANI PHARMACEUTICALS INC - Common Stock (ANIP)
CUSIP: 00182C103
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,278,088
- Total 13F shares
- 13,199,659
- Share change
- +874,731
- Total reported value
- $766,379,240
- Put/Call ratio
- 108%
- Price per share
- $58.06
- Number of holders
- 184
- Value change
- +$52,240,515
- Number of buys
- 99
- Number of sells
- 66
Quarterly Holders Quick Answers
What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00182C103:
Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
9.6%
|
2,133,100
|
$114,824,773 | — | 30 Jun 2023 | |
| MERIDIAN VENTURE PARTNERS II LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,819,259
|
$102,678,978 | — | 16 Aug 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.8%
|
1,074,174
|
$57,822,787 | — | 30 Jun 2023 | |
| Rubric Capital Management LP |
13F
|
Company |
3.8%
|
847,011
|
$45,594,602 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
543,942
|
$29,280,264 | — | 30 Jun 2023 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
539,128
|
$29,021,260 | — | 30 Jun 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
2.3%
|
514,021
|
$27,669,750 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
486,406
|
$26,183,235 | — | 30 Jun 2023 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
2%
|
453,328
|
$24,402,646 | — | 30 Jun 2023 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
2%
|
445,157
|
$23,962,801 | — | 30 Jun 2023 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
1.6%
|
362,291
|
$19,502,000 | — | 30 Jun 2023 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.6%
|
350,325
|
$18,857,995 | — | 30 Jun 2023 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
309,887
|
$16,681,217 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
263,701
|
$14,195,024 | — | 30 Jun 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.2%
|
257,912
|
$13,883,403 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.82%
|
181,833
|
$9,788,071 | — | 30 Jun 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.78%
|
174,477
|
$9,392,097 | — | 30 Jun 2023 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.78%
|
174,276
|
$9,381,277 | — | 30 Jun 2023 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.76%
|
168,655
|
$9,079,000 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
154,552
|
$8,319,534 | — | 30 Jun 2023 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.65%
|
145,276
|
$7,820,207 | — | 30 Jun 2023 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.6%
|
134,571
|
$7,243,957 | — | 30 Jun 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.54%
|
120,794
|
$6,502,339 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.53%
|
119,045
|
$6,408,193 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.51%
|
113,483
|
$6,108,790 | — | 30 Jun 2023 | |
| WEDGE CAPITAL MANAGEMENT L L P/NC |
13F
|
Company |
0.48%
|
107,478
|
$5,785,541 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
91,212
|
$4,909,943 | — | 30 Jun 2023 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.39%
|
87,472
|
$4,708,618 | — | 30 Jun 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.37%
|
81,956
|
$4,411,692 | — | 30 Jun 2023 | |
| Phocas Financial Corp. |
13F
|
Company |
0.34%
|
75,285
|
$4,053,000 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.33%
|
73,215
|
$3,941,163 | — | 30 Jun 2023 | |
| CVI Holdings, LLC |
13F
|
Company |
0.31%
|
70,009
|
$3,768,584 | — | 30 Jun 2023 | |
| MARATHON CAPITAL MANAGEMENT |
13F
|
Company |
0.31%
|
68,645
|
$3,695,160 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
61,302
|
$3,300,000 | — | 30 Jun 2023 | |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC |
13F
|
Company |
0.25%
|
56,244
|
$3,028,000 | — | 30 Jun 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
54,041
|
$2,909,027 | — | 30 Jun 2023 | |
| Robert E. Brown Jr. |
3/4/5
|
Director |
—
class O/S missing
|
49,021
|
$2,766,745 | — | 27 Apr 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.22%
|
50,000
|
$2,691,500 | — | 30 Jun 2023 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.21%
|
47,443
|
$2,553,839 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.21%
|
46,283
|
$2,491,414 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
40,940
|
$2,203,801 | — | 30 Jun 2023 | |
| David Nash |
3/4/5
|
Director |
—
class O/S missing
|
38,561
|
$2,176,383 | — | 23 May 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.17%
|
38,204
|
$2,056,520 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
37,974
|
$2,044,140 | — | 30 Jun 2023 | |
| Trexquant Investment LP |
13F
|
Company |
0.17%
|
37,919
|
$2,041,180 | — | 30 Jun 2023 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.17%
|
37,546
|
$2,022,000 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.16%
|
34,984
|
$1,883,188 | — | 30 Jun 2023 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.15%
|
32,904
|
$1,771,222 | — | 30 Jun 2023 | |
| Swiss National Bank |
13F
|
Company |
0.15%
|
32,400
|
$1,744,092 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0.14%
|
32,073
|
$1,726,490 | — | 30 Jun 2023 |
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q3 2023
As of 30 Sep 2023,
ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by
184 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,199,659 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Rubric Capital Management LP, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Global Alpha Capital Management Ltd., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Ranger Investment Management, L.P., Deep Track Capital, LP, and Invesco Ltd..
This page lists
184
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
169
Q3 2023 holders
184
Holder diff
15
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.